Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1583.

Immunologic targets in psoriasis.

N. Engl. J. Med.
Kupper TS.
| Nov 20, 2003
1585.

Opioid therapy for chronic pain.

N. Engl. J. Med.
Ballantyne JC, Mao J.
| Nov 13, 2003
1586.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

N. Engl. J. Med.
Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM, Pffeffer M.
| Nov 13, 2003
1587.

Clinical research and the NIH--a report card.

N. Engl. J. Med.
Nathan DG, Wilson JD.
| Nov 06, 2003
1589.

Images in clinical medicine. Isolated right ventricular infarction.

N. Engl. J. Med.
Finn AV, Antman EM.
| Oct 23, 2003
1590.

The GPR54 gene as a regulator of puberty.

N. Engl. J. Med.
Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF, Aparicio SA, Colledge WH.
| Oct 23, 2003
1591.

Bench and bedside--the G protein-coupled receptor GPR54 and puberty.

N. Engl. J. Med.
Beier DR, Dluhy RG.
| Oct 23, 2003
1593.

Autoantibodies in systemic lupus erythematosus--there before you know it.

N. Engl. J. Med.
Shmerling RH.
| Oct 16, 2003
1594.

How often should we screen for cervical cancer?

N. Engl. J. Med.
Feldman S.
| Oct 16, 2003
1595.

Clinical problem-solving. Mind the gap.

N. Engl. J. Med.
Turchin A, Seifter JL, Seely EW.
| Oct 09, 2003
1596.

Chronic constipation.

N. Engl. J. Med.
Lembo A, Camilleri M.
| Oct 02, 2003
1598.

Epilepsy.

N. Engl. J. Med.
Chang BS, Lowenstein DH.
| Sep 25, 2003
1599.

The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.

N. Engl. J. Med.
Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM.
| Sep 25, 2003